Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times

Maharashtra FDA cancels Cipla's Pune warehouse licences over Reactin Plus packaging claims

Maharashtra's Food and Drug Administration (FDA) has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd's Warehouse No. A at Vadki in Pune, following fresh proceedings over violations involving the prescription drug Reactin Plus Tablets and irregularities found during inspections.

Cipla Pharma & Life Sciences Ltd, a unit of drugmaker Cipla Ltd, operates the warehouse.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.